ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
- 26 August 2025
- journal article
- review article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (10)
Abstract
Alzheimer’s disease (AD), the most common cause of dementia, is characterized by the accumulation of amyloid-β (Aβ) in senile plaques and abnormally hyperphosphorylated tau proteins in neurofibrillary tangles. While much of the research has focused on Aβ, tau-mediated neurodegeneration is more closely associated with synaptic loss and cognitive decline in AD, emphasizing the need for a deeper understanding of tau pathology. In this context, the interaction between tau and APOE, particularly the main genetic risk factor for AD APOE ε4, remains underexplored. APOE encodes apolipoprotein E (apoE), a protein important in lipid metabolism. In addition to promoting Aβ deposition, emerging evidence suggests that APOE ε4 exacerbates tau-mediated neurodegeneration and tau-related pathology. This review consolidates current knowledge on the interplay between apoE and tau, highlighting its potential as a key factor in disease progression. Targeting the apoE–tau axis may offer promising therapeutic strategies to address the molecular mechanisms driving AD and primary tauopathies.Keywords
This publication has 363 references indexed in Scilit:
- Amyloid-Related Imaging Abnormalities and β-Amyloid–Targeting AntibodiesJAMA Neurology, 2022
- Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-βJAMA Neurology, 2020
- Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older AdultsJAMA Network Open, 2019
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology, 2019
- Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseJAMA Neurology, 2019
- Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of TauJAMA Neurology, 2018
- Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal FunctionJAMA Neurology, 2014
- Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob DiseaseJAMA Neurology, 2014
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer DementiaArchives of General Psychiatry, 2012
- Neurochemical Aftermath of Amateur BoxingArchives of Neurology, 2006